List of Excipients in API abiraterone acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing abiraterone acetate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Janssen Biotech Inc | ZYTIGA | abiraterone acetate | 57894-150 | CELLULOSE, MICROCRYSTALLINE | |
| Janssen Biotech Inc | ZYTIGA | abiraterone acetate | 57894-150 | CROSCARMELLOSE SODIUM | |
| Janssen Biotech Inc | ZYTIGA | abiraterone acetate | 57894-150 | LACTOSE MONOHYDRATE | |
| Janssen Biotech Inc | ZYTIGA | abiraterone acetate | 57894-150 | MAGNESIUM STEARATE | |
| Janssen Biotech Inc | ZYTIGA | abiraterone acetate | 57894-150 | POVIDONE | |
| Janssen Biotech Inc | ZYTIGA | abiraterone acetate | 57894-150 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing abiraterone acetate
Detailed excipient profiles for abiraterone acetate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
abiraterone acetate drug variants containing CELLULOSE, MICROCRYSTALLINE
abiraterone acetate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
abiraterone acetate drug variants containing CROSCARMELLOSE SODIUM
abiraterone acetate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | abiraterone acetate | 0904-6948 |
| Apotex Corp | abiraterone acetate | 60505-4327 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
abiraterone acetate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | abiraterone acetate | 0904-6948 |
| Apotex Corp | abiraterone acetate | 60505-4327 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE RED
abiraterone acetate drug variants containing FERRIC OXIDE RED
abiraterone acetate drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
abiraterone acetate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | abiraterone acetate | 0591-4365 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
abiraterone acetate drug variants containing FERROSOFERRIC OXIDE
abiraterone acetate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
abiraterone acetate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | abiraterone acetate | 0591-4365 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE 2910
abiraterone acetate drug variants containing HYPROMELLOSE 2910
abiraterone acetate drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
abiraterone acetate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | abiraterone acetate | 16714-963 |
| Dr Reddys Laboratories Inc | abiraterone acetate | 43598-358 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
abiraterone acetate drug variants containing LACTOSE MONOHYDRATE
abiraterone acetate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
abiraterone acetate drug variants containing MAGNESIUM STEARATE
abiraterone acetate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
abiraterone acetate drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6921 |
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6924 |
| Golden State Medical Supply Inc | abiraterone acetate | 51407-181 |
| Bryant Ranch Prepack | abiraterone acetate | 72162-2151 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
abiraterone acetate drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6921 |
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6924 |
| Golden State Medical Supply Inc | abiraterone acetate | 51407-181 |
| Bryant Ranch Prepack | abiraterone acetate | 72162-2151 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYDEXTROSE
abiraterone acetate drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6921 |
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6924 |
| Bryant Ranch Prepack | abiraterone acetate | 72162-2151 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
abiraterone acetate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar Rx LLC | abiraterone acetate | 16714-963 |
| Dr Reddys Laboratories Inc | abiraterone acetate | 43598-358 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
abiraterone acetate drug variants containing POLYETHYLENE GLYCOL 3350
abiraterone acetate drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
abiraterone acetate drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | abiraterone acetate | 0093-1125 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
abiraterone acetate drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6921 |
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6924 |
| Bryant Ranch Prepack | abiraterone acetate | 72162-2151 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
abiraterone acetate drug variants containing POLYVINYL ALCOHOL
abiraterone acetate drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
abiraterone acetate drug variants containing POVIDONE
abiraterone acetate drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
abiraterone acetate drug variants containing POVIDONE K30
abiraterone acetate drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
abiraterone acetate drug variants containing SILICON DIOXIDE
abiraterone acetate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
abiraterone acetate drug variants containing SODIUM LAURYL SULFATE
abiraterone acetate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
abiraterone acetate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | abiraterone acetate | 0143-9597 |
| PD-Rx Pharmaceuticals Inc | abiraterone acetate | 72789-213 |
| CivicaScript LLC | abiraterone acetate | 82249-010 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: TALC
abiraterone acetate drug variants containing TALC
abiraterone acetate drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
abiraterone acetate drug variants containing TITANIUM DIOXIDE
abiraterone acetate drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
abiraterone acetate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6921 |
| Mylan Pharmaceuticals Inc | abiraterone acetate | 0378-6924 |
| Bryant Ranch Prepack | abiraterone acetate | 72162-2151 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing TRIACETIN
Excipient focus: WATER
abiraterone acetate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | abiraterone acetate | 60505-4764 |
| >Company | >Ingredient | >NDC |
abiraterone acetate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
